ArnoldJayWeilMDMBA

PubMed

• 33 citations
  Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain
  Bruce Nicholson, Edgar L. Ross, John Sasaki, Arnold J. Weil
  Current Medical Research and Opinion. 2006-06-27
• 10 citations
  Cyclobenzaprine ER for muscle spasm associated with low back and neck pain: two randomized, double-blind, placebo-controlled studies of identical design.
  Gerard A. Malanga, Gary E. Ruoff, Arnold J. Weil, Charles A. Altman, Fang Xie
  Current Medical Research and Opinion. 2009-04-29
• 6 citations
  Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered na...
  Arnold J. Weil, Elizabeth T. Masters, Alexandra I. Barsdorf, Almasa Bass, Glenn C. Pixton
  Health and Quality of Life Outcomes. 2017-10-17

Journal Articles

• High Molecular Weight Hyaluronan for Treatment of Chronic Shoulder Pain Associated with Glenohumeral Arthritis.  
  Arnold J. Weil, Medical Devices: Evidence and Research
• Factors affecting dosing regimens of morphine sulfate extended-release (KADIAN) capsules.  
  Arnold J. Weil, Journal of Opioid Management
• Cyclobenzaprine ER for Muscle Spasm Associated With Low Back and Neck pain: Two Randomized, Double-Blind, Placebo-Controlled Studies of Identical Design.  
  Arnold J. Weil, Current Medical Research and Opinion
• Non-Surgical Orthopaedics & Pain Management.  
  Arnold J. Weil, CE presentation to the Georgia Chiropractic Association
• Managing the Patient with Chronic Pain.  
  Arnold J. Weil, Clinical Bulletin
• Tolerability of once-daily cyclobenzaprine hydrochloride modified-release 15 mg and 30 mg for low back and neck pain associated with muscle spasm.  
  Arnold J. Weil, Journal of Pain
• Assessing Quality of Life: Focus on Sustained-release Opioids.  
  Arnold J. Weil, The Clinical Journal of Pain
• Assessing Pain: Focus on Sustained-release Opioids.  
  Arnold J. Weil, The Royal Society of Medicine Press
• The 10-Minute Examination for Low Back Pain.  
  Arnold J. Weil, The Journal of Musculoskeletal Medicine
• Join now to see all

Abstracts/Posters

• Treatment of Chronic Neck Pain Using Polymer-Coated Extended-Release Morphine Sulfate Capsules.
  Arnold J. Weil, 67th Annual Assembly of the AAPM&R, Honolulu, Hawaii
• High Molecular Weight Hyaluronan for Treatment of Chronic Shoulder Pain Associated with Glenohumeral Arthritis.
  Arnold J. Weil, OARSI, San Diego, CA
• Patients With Chronic, Non-malignant, Moderate/Severe Pain Can Be Successfully Switched from Other Sustained-Release Morphine or Oxycodone Compounds to Kadian ® (m...
  Arnold J. Weil, The American Pain Society Meeting, Quebec, Canada
• Improved quality of life with Kadian ® (morphine sulfate sustained-release capsules) in patients with chronic non-malignant, moderate/severe pain: The KRONUS-MSP Tr...
  Arnold J. Weil, The American Society of Regional Anesthesia & Pain Medicine Meeting, Phoenix, Arizona
• Effect of Demographic Factors and Outcomes on Kadian ® Once- or Twice- Daily Dosing.
  Arnold J. Weil, The American Academy of Pain Medicine Meeting, Palm Springs, CA
• The Efficacy and Tolerability of Kadian ® (morphine-sulfate sustained-release capsules) in Elderly Patients With Persistent Non-malignant Moderate / Severe Pain.
  Arnold J. Weil, Meeting of the American Geriatrics Society, Orlando, FL
• Treatment of neuropathic pain with Kadian ® in poor responders to other pain medications.
  Arnold J. Weil, The Journal of Pain
• Efficacy and tolerability of polymer-coated sustained-release morphine sulfate (KADIAN®) at doses of 200 mg/day or greater in the treatment of moderate to severe nonc...
  Arnold J. Weil, American Academy of Nurse Practitioners, Fort Lauderdale, FL
• Dealing with Treatment Adherence Issues in Acute Conditions.
  Arnold J. Weil, Resident & Staff Physician
• Long-term effects of extended-release morphine sulfate (Kadian®) vs controlled-release oxycodone HCL (OxyContin®) on relief of moderate to severe pain.
  Arnold J. Weil, American Academy of Physical Medicine & Rehabilitation (AAPM&R) 66th Annual Assembly, Philadelphia, PA
• Treatment of chronic, moderate to severe, non-malignant pain with KADAIN® using individualized doses and dosing frequencies.
  Arnold J. Weil, Southern Medical Association (SMA) 99th Annual Scientific Assembly, San Antonio, Texas
• Capsules for chronic non-malignant pain in patients aged ? 75 years.
  Arnold J. Weil, American Pain Society 25th Annual Meeting, San Antonio, Texas
• Opioid Use Among Patients With Chronic Non-Malignant Pain Receiving Methylnaltrexone For Opioid-Induced Constipation.
  Arnold J. Weil, The 13th World Congress on Pain / IASP, Montreal, Quebec, Canada
• Efficacy of Cyclobenzaprine Hydrochloride Extended-Release 15 mg and 30 mg Once- Daily For Low Back and Neck Pain Associated with Muscle Spasms: A Pooled Analysis of...
  Arnold J. Weil, American Academy of Pain Medicine Annual Meeting, Orlando, Florida
• Efficacy and Tolerability of Once-Daily Cyclobenzaprine HCl Extended-Release 15 mg and 30 mg for Low Back and Neck Pain Associated With Muscle Spasm.
  Arnold J. Weil, American Pain Society 27th Annual Meeting, Tampa, Florida
• Correspondence of the Pharmacokinetics and Efficacy of Once-Daily Cyclobenzaprine Extended-Release.
  Arnold J. Weil, AAPM
• New Advances in Pain Management.
  Arnold J. Weil, Multiple presentations to physicians nationally
• Relationship Between the Pharmacokinetics and Efficacy of Once-Daily Cyclobenzaprine Extended-Release.
  Arnold J. Weil, AAPM
• Correspondence of the Pharmacokinetics and Efficacy of Once-Daily Cyclobenzaprine Extended-Release.
  Arnold J. Weil, PainWeek 2009 National Conference
• Cyclobenzaprine extended release for acute low back and neck pain.
  Arnold J. Weil, Therapy Vol.6 No.6
• Cyclobenzaprine Extended-Release: The Difference is in the Formulation.
  Arnold J. Weil, Pharmacy Times
• Subcutaneous Methylnaltrexone Improves Bowel Movement Frequency and Quality in Patients with Chronic, Non-Malignant Pain and Opioid Induced Constipation.
  Arnold J. Weil, APS, Baltimore, MD
• Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic, Non-Malignant Pain: Safety Results in Patients Treated for ...
  Arnold J. Weil, APS, Baltimore, MD
• Join now to see all

Lectures

• Non-Surgical Management of Low Back Pain. 
  Institute of Continuing Legal Education in Georgia (2002)
• New Advances in Interventional Pain Management. 
  North Shore Long Island Jewish Health System
• Non-Surgical Management of Back & Neck Pain. 
  Institute of Continuing Legal Education in Georgia
• Issues in Workers’ Comp; Aggravation of a Pre-Existing Injury vs. a New Injury. 
  Lectures to various organizations and insurance companies, locally and nationally
• Management of Soft Tissue Injuries. 
  Institute of Continuing Legal Education in Georgia
• Fibromyalgia and Workers' Compensation Injuries. 
  GSIA Annual Meeting; Calloway Gardens, Georgia
• Degenerative Spine Conditions; Non-Surgical Treatment of Back Pain. 
  Atlanta Arthritis Foundation
• Rehabilitation of the Chronic Pain Patient. 
  6th International Congress - Pain Clinic; Atlanta, Georgia
• Rehabilitation of Neck and Shoulder Pain. 
  6th International Congress - Pain Clinic; Atlanta, Georgia
• Low Back Pain: Prevention and Management. 
  Monthly Seminars
• Rehabilitation in the 90's. 
  The Cobb County Women'sInsurance Auxiliary Meeting
• Functional Restoration Programs for Chronic Pain Management. 
  The Private Rehabilitation Suppliers of Georgia Seminar
• Public Policy Issues in Rehabilitation: A Model for Resident Participation. 
  The Pennsylvania Society of PM&R Annual Meeting
• Public Policy Issues in Rehabilitation: A Model for Increased Resident Awareness. 
  Archives of Physical Medicine and Rehabilitation
• Join now to see all

Other

• Conducting & Managing Clinical Research at Small Sites 
  MAGI, MAGI's Clinical Research Conference 2011
  Las Vegas